Avondale Wealth Management Moderna, Inc. Transaction History

Avondale Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$126.46 - $235.05 $83,463 - $155,133	-660 Closed	0 $0
Q4 2021 Jan 11, 2022	BUY	$225.82 - $368.51 $149,041 - $243,216	660 New	660 $168,000
Q2 2021 Jul 13, 2021	SELL	$129.91 - $234.98 $415,712 - $751,936	-3,200 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$109.18 - $185.98 $327,540 - $557,940	3,000 Added 1500.0%	3,200 $419,000
Q4 2020 Jan 15, 2021	SELL	$65.74 - $169.86 $27,347 - $70,661	-416 Reduced 67.53%	200 $21,000
Q3 2020 Oct 15, 2020	BUY	$54.34 - $94.85 $33,473 - $58,427	616 New	616 $44,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Avondale Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Avondale Wealth Management with notifications on news.